Bd submits pre-market approval supplement to fda for bd onclarity hpv test with extended genotyping capabilities

Bd submits pre-market approval supplement to fda for bd onclarity™ hpv test with extended genotyping capabilities.becton dickinson - supplement seeks approval for genotype reporting beyond hpv genotypes 16, 18, & 45 to include types 31, 51, 52 & 8 additional types.
BDX Ratings Summary
BDX Quant Ranking